Brendan M. Finnerty

Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen—a Possible Novel Therapeutic Target

Maureen D. Moore, Suraj Panjwani, Rashmi G. Mathew et al. · Endocrine Pathology · 2017 · 45 citations

Tumor Biology, Urology, Genitourinary Cancer +7

Features Associated With Metastases Among Well-Differentiated Neuroendocrine (Carcinoid) Tumors of the Appendix

David A. Kleiman, Brendan M. Finnerty, Toni Beninato et al. · Diseases of the Colon & Rectum · 2015 · 33 citations

Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors

Jessica L. Buicko, Brendan M. Finnerty, Tiantian Zhang et al. · Annals of Pancreatic Cancer · 2019 · 30 citations · Full text

UCHL1 loss alters the cell cycle in metastatic pancreatic neuroendocrine tumors

Brendan M. Finnerty, Maureen D. Moore, Akanksha Verma et al. · Endocrine Related Cancer · 2019 · 20 citations · Full text

Cpg Promoter Hypermethylation, Pancreatic Cancer, Malignant Disease +15

Silencing of UCHL1 by CpG Promoter Hyper-methylation is Associated with Metastatic Gastroenteropancreatic Well-Differentiated Neuroendocrine (Carcinoid) Tumors

David A. Kleiman, Toni Beninato, Samuel Sultan et al. · Annals of Surgical Oncology · 2014 · 19 citations · Full text

Cpg Promoter Hyper-methylation, Medicine, Pathology +7